Cyclophosphamide and Azathioprine vs Tacrolimus in Antisynthetase Syndrome-related Interstitial Lung Disease

Clinical trial NCT03770663 · UNKNOWN

Trial details

NCT number: NCT03770663
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Antisynthetase Syndrome (ASS)Interstitial Lung Disease

Start date: 2021-02-05
Primary completion: 2024-01-02
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.